首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >Pilot Study of the Efficacy of Oral Sodium Diclofenac in the Management of Postoperative Pain after Transepithelial Photorefractive Keratectomy
【24h】

Pilot Study of the Efficacy of Oral Sodium Diclofenac in the Management of Postoperative Pain after Transepithelial Photorefractive Keratectomy

机译:口服双氯芬酸钠在经皮上屈光性角膜切除术术后疼痛管理中的临床研究

获取原文
       

摘要

Purpose of this study is to study the efficacy of oral sodium diclofenac in the management of postoperative pain after transepithelialphotorefractive keratectomy (tPRK). In this pilot study, 60 patients were included. They were divided into two equal groups. Thepatients in the control group did not get oral sodium diclofenac in their prescriptions. However, the patients in the diclofenac groupgot sodium diclofenac 50 mg tab as an addition to the ordinary prescription. Patients were asked to assess their level of pain, pho-tophobia, their functional activity restriction and to specify the number of oral analgesic combi-nation pills, and the number ofmidazolam pills they have taken till the third day after surgery. Pain intensity in the diclofenac group was significantly less than thatin the control group on the day of surgery and on the first day after surgery (p-value=0.01, p-value=0.03 respectively). The functionalactivity restriction after surgery was remarkably less in the diclofenac group than it was in the control group (p-value=0.01). Therewas no statistically significant difference between the two groups in terms of photophobia after the surgery (p-value=0.3). Therewas no important difference between the two groups in terms of the mean number of oral analgesic combination pills consumedby patients (p-value>0.05), and so for the mean number of midazolam pills (p-value>0.05). Oral sodium diclofenac is significantlyeffective in the management of postoperative pain after tPRK. It also decreases the degree of functional activity restriction. Thereis no significant effect of oral sodium diclofenac on post-operative photophobia.
机译:这项研究的目的是研究口服双氯芬酸钠治疗经上皮光折光性角膜切除术(tPRK)后术后疼痛的疗效。在该初步研究中,纳入了60名患者。他们分为两组。对照组患者未按处方服用口服双氯芬酸钠。但是,双氯芬酸组中的患者除了常规处方外,还服用了双氯芬酸钠50 mg片。要求患者评估他们的疼痛程度,恐惧症,功能活动受限程度,并指定直到手术后第三天服用的口服止痛组合药的数量以及服用咪达唑仑的药的数量。双氯芬酸组在手术当天和术后第一天的疼痛强度明显低于对照组(p值= 0.01,p值= 0.03)。双氯芬酸组手术后的功能活性限制明显低于对照组(p值= 0.01)。两组在手术后的畏光方面无统计学差异(p值= 0.3)。两组患者就口服止痛药的平均服用量(p值> 0.05)没有差异,而咪达唑仑的平均服用量(p值> 0.05)也没有重要差异。口服双氯芬酸钠对tPRK术后疼痛有显着疗效。它还降低了功能活性限制的程度。口服双氯芬酸钠对术后畏光没有明显作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号